Zimmer Biomet Issues $1 Billion in Senior Notes
Zimmer Biomet Holdings ( ($ZBH) ) has provided an update. On November 5, 2026, Zimmer Biomet Holdings entered underwriting agreements for €500.0 million of 4.375% notes due 2033 and $500.0
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 ZBH | Healthcare | $103.06 | 1.65M | $20.34B | 26.36 | 0.92% | Hold |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ZBH | Zimmer Biomet Holdings | 103.06 | 14.74 | 16.68% |
| Name | Price | % Change | |
|---|---|---|---|
| ZBH | $103.06 | +16.68% |
Custom Stock Latest News
Zimmer Biomet price target raised to $115 from $100 at BarclaysBarclays raised the firm’s price target on Zimmer Biomet (ZBH) to $115 from $100 and keeps an Equal Weight rating on the shares. The company showed encouraging progress excluding knees
4d agoZBH
Zimmer Biomet price target raised to $114 from $106 at TruistTruist analyst Richard Newitter raised the firm’s price target on Zimmer Biomet (ZBH) to $114 from $106 and keeps a Hold rating on the shares. Q3 saw another quarter of
1w agoZBH
Zimmer Biomet price target raised to $125 from $110 at RBC CapitalRBC Capital raised the firm’s price target on Zimmer Biomet (ZBH) to $125 from $110 and keeps an Outperform rating on the shares. The firm cites the company’s Q3 earnings
1w agoZBH
Zimmer Biomet price target raised to $120 from $117 at JPMorganJPMorgan analyst Robbie Marcus raised the firm’s price target on Zimmer Biomet (ZBH) to $120 from $117 and keeps a Neutral rating on the shares. Published first on TheFly –
1w agoZBH- Zimmer Biomet price target raised to $130 from $120 at UBS
UBS raised the firm’s price target on Zimmer Biomet (ZBH) to $130 from $120 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source
1w agoZBH 
Zimmer Biomet price target raised to $111 from $100 at CanaccordCanaccord analyst Caitlin Cronin raised the firm’s price target on Zimmer Biomet (ZBH) to $111 from $100 and keeps a Hold rating on the shares. The firm said they delivered
1w agoZBH
Zimmer Biomet price target raised to $125 from $110 at StifelStifel raised the firm’s price target on Zimmer Biomet (ZBH) to $125 from $110 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source
1w agoZBH- Zimmer Biomet’s Raised Outlook and Strong Results Tempered by Knee Weakness and Execution Risks — Hold
BTIG analyst Ryan Zimmerman has maintained their neutral stance on ZBH stock, giving a Hold rating today. Ryan Zimmerman’s rating is based on a combination of encouraging results and persistent
1w agoZBH 
Zimmer Biomet price target raised to $114 from $104 at BairdBaird raised the firm’s price target on Zimmer Biomet (ZBH) to $114 from $104 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results
1w agoZBH
Recent Analysts Ratings of Custom Stocks
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| ZBH | hold | Reiterated | Nov 9, 2026 | |||
| ZBH | hold | Reiterated | Nov 9, 2026 | |||
| ZBH | hold | Reiterated | Nov 5, 2026 | |||
| ZBH | hold | Reiterated | Nov 5, 2026 | |||
| ZBH | hold | Assigned | Nov 5, 2026 | |||
| ZBH | hold | Reiterated | Nov 5, 2026 | |||
| ZBH | hold | Reiterated | Nov 5, 2026 | |||
| ZBH | buy | Reiterated | Nov 5, 2026 | |||
| ZBH | buy | Assigned | Nov 5, 2026 | |||
| ZBH | hold | Assigned | Nov 5, 2026 |
Most Recent Earnings of Custom Stocks
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| ZBH | Feb 11, 2027TBA | $20.34B | $2.49 | $2.29B | -1.26 | 26.36 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
Zimmer Biomet Holdings's stock price is currently $103.06, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
Zimmer Biomet Holdings currently pays a dividend of $0.24 which represents an annual dividend yield of 0.92%. Zimmer Biomet Holdings's next Ex-dividend date is N/A and its next payout date is N/A.